Prostate cancer doesn’t have a single cause. It develops when cells in the prostate gland accumulate DNA damage over time, eventually growing and dividing in ways the body can no longer control. What drives that damage varies from person to person, but the major contributors are age, hormones, inherited genetics, and a range of lifestyle and environmental factors that interact in complex ways. About 95% of cases are diagnosed in men 55 and older, making it overwhelmingly a disease of aging.
How Prostate Cells Become Cancerous
At the molecular level, prostate cancer begins when key genes that regulate cell growth are damaged or rearranged. One of the most common changes involves a tumor-suppressing gene called PTEN, which normally acts as a brake on cell division. PTEN is deleted or inactivated in roughly 40 to 50% of primary prostate cancers. When it stops working, cells lose a critical growth checkpoint and begin multiplying unchecked.
Another hallmark of prostate cancer is a type of genetic rearrangement called a gene fusion. In most prostate cancers, a gene that responds to male hormones fuses with a cancer-promoting gene, creating a hybrid that essentially hijacks the hormone signaling system to fuel tumor growth. These fusions are considered a defining feature of the disease and help explain why prostate cancer is so tightly linked to hormones. Additional mutations in genes that control the cell cycle and how DNA is packaged also accumulate, collectively pushing normal prostate tissue toward cancer.
The Role of Male Hormones
Testosterone and its more potent derivative, dihydrotestosterone (DHT), are central to both normal prostate function and prostate cancer development. These hormones bind to androgen receptors inside prostate cells, switching on genes that drive cell growth. In a healthy prostate, this process is tightly regulated. In cancer, the system goes haywire.
Cancer cells can become hypersensitive to even low levels of hormones. Some tumors overload themselves with androgen receptors, meaning they respond to hormone concentrations that would barely register in normal tissue. Others develop mutations that allow the receptor to be activated by hormones it wouldn’t normally respond to, including estrogen and progesterone. This is one reason prostate cancer can continue growing even after treatments designed to slash testosterone levels. The cancer essentially learns to work with whatever hormones are available.
Age and the Accumulation of Damage
Age is the single strongest risk factor. Prostate cancer is rare before 40 and uncommon before 50. In 2022, just 5% of cases were diagnosed in men aged 45 to 54, while 52% were diagnosed between 55 and 69, and 43% in men 70 or older. This pattern reflects the simple reality that DNA damage builds up over decades. The longer prostate cells divide, the more opportunities mutations have to occur and escape the body’s repair mechanisms.
Inherited Genetic Risk
An estimated 5 to 10% of prostate cancers are strongly hereditary, driven by mutations passed from parent to child. Having a father or brother with prostate cancer roughly doubles your risk, and the risk increases further with multiple affected family members or relatives diagnosed at a young age.
Several specific genes are now linked to inherited risk. Mutations in BRCA2, better known for its connection to breast cancer, significantly raise the likelihood of developing prostate cancer and are associated with more aggressive disease. BRCA1 mutations carry a smaller but real increase in risk. A rarer mutation in a gene called HOXB13 is found in about 3% of men with early-onset, familial prostate cancer, compared to just 0.1% of the general population. Men who carry this mutation are roughly 20 times more likely to develop the disease. Current guidelines increasingly recommend genetic counseling and testing for men with strong family histories.
Beyond these high-impact mutations, researchers have identified more than 30 common genetic variants that each nudge risk upward by a small amount. Individually, none of these variants is powerful, raising risk by less than 30% each. But collectively, they may account for about a quarter of the familial clustering seen in prostate cancer.
Racial Disparities in Risk
Black men face significantly higher prostate cancer risk than any other racial group, and the gap is stark. In the United States, incidence among Black men is 64% higher than among white men, and the mortality rate is 2.3 times higher. Compared to Asian American men, Black men have incidence and mortality rates three to four times greater. European and updated international guidelines now recommend that men of African descent begin screening conversations at age 45, five years earlier than the general population.
The reasons for this disparity are layered. Genetic factors play a role: certain inherited variants that raise prostate cancer risk are more common in men of African ancestry. But differences in access to healthcare, screening rates, treatment quality, and socioeconomic factors also contribute significantly to the mortality gap. Biology and systemic inequality both matter here.
Chronic Inflammation
Long-term inflammation in the prostate appears to increase cancer risk, though the exact mechanism is still being refined. A large study of over 1.4 million men found that those with a history of prostatitis (prostate inflammation or infection) had a prostate cancer incidence of 1.8%, compared to 0.6% in men without prostatitis. That translates to roughly three times the risk. Interestingly, acute prostatitis carried a higher risk than the chronic form, with nearly four times the likelihood of a later cancer diagnosis.
The underlying logic is straightforward. When tissue is inflamed, cells divide more rapidly to repair damage, and the local environment is flooded with molecules that can cause DNA mutations. Over years, this cycle of damage and repair creates fertile ground for cancerous changes. Sexually transmitted infections, urinary tract infections, and other sources of prostate inflammation may all contribute.
Obesity and Metabolic Health
The relationship between body weight and prostate cancer is more nuanced than a simple “higher weight, higher risk” equation. Obesity does not consistently raise the overall rate of prostate cancer diagnosis. In some studies, it is even associated with a lower rate of low-grade tumors, possibly because excess body fat lowers testosterone levels and makes screening less accurate.
Where obesity consistently shows its impact is in cancer aggressiveness. Men who are obese at the time of diagnosis are more likely to have high-grade, fast-growing tumors, and they face higher prostate cancer mortality. The likely mechanisms involve insulin resistance and elevated levels of insulin-like growth factors, which can promote tumor growth. Excess fat tissue also produces estrogen and inflammatory compounds that may push existing cancer cells toward more dangerous behavior.
Diet and Dairy Intake
Diet is one of the more debated risk factors, but the evidence around dairy and saturated fat is reasonably consistent. Total dairy intake and the calcium it provides have been positively linked to prostate cancer risk. Low-fat milk appears more associated with non-aggressive disease, while whole milk consumption is tied to a greater risk of fatal prostate cancer. Adults who consumed diets high in saturated fat, including whole milk, had an 80% increased risk compared to those with lower intake.
High-fat dairy products raise levels of a molecule called c-peptide, a marker of insulin production, which has been linked to aggressive tumor development. Diets heavy in red and processed meats may contribute through similar insulin-related pathways and through compounds formed during high-heat cooking. On the protective side, diets rich in tomatoes (which contain the antioxidant lycopene), cruciferous vegetables, and fish have shown modest associations with lower risk in some studies, though the evidence is less definitive.
Environmental and Chemical Exposures
Certain chemical exposures are officially recognized as prostate cancer risk factors. Agent Orange, the herbicide widely used during the Vietnam War, is the most well-established. The U.S. Department of Veterans Affairs grants disability benefits to exposed veterans who develop prostate cancer without requiring them to prove a direct connection. A 2013 study at the Portland VA Medical Center found that exposed veterans were not only at higher risk but more likely to develop aggressive forms of the disease.
Occupational exposure to pesticides, cadmium (found in welding and battery manufacturing), and certain industrial chemicals has also been associated with elevated risk, though the evidence for individual compounds is less robust than for Agent Orange. Firefighters face higher prostate cancer rates, likely due to repeated exposure to combustion byproducts and per- and polyfluoroalkyl substances in firefighting foam.
Why No Single Cause Explains It
Prostate cancer is ultimately the product of many factors converging over a lifetime. A man might inherit a genetic variant that modestly raises his risk, spend decades exposed to hormones that drive prostate cell growth, accumulate random DNA mutations through normal aging, and encounter dietary or environmental triggers that tip the balance. No single factor is necessary or sufficient on its own. This is why two men with similar lifestyles can have very different outcomes, and why a man with no known risk factors can still be diagnosed. The factors you can influence, like body weight, diet, and awareness of your family history, represent your best opportunities to shift the odds.